Sector dividends Palvella Therapeutics, Inc.
Equities
PVLA
US6979471090
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 140.16 USD | -1.37% |
|
+4.69% | +35.51% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | -40.43x | - | - | -48.77x | -48.75x | 1.91B | ||
| 0.03% | 0.05% | 43.19x | 6.77x | 10.11x | 36.48x | 37.2x | 45.56B | ||
| 1.85% | 1.66% | 16.15x | 3.9x | 5.76x | 12.69x | 13.87x | 40.81B | ||
| -.--% | -.--% | -53.49x | 93.4x | 18.02x | -59.54x | -58.71x | 31.01B | ||
| -.--% | -.--% | -16.58x | 1x | 2.76x | -13.85x | -4.56x | 21.05B | ||
| -.--% | -.--% | 28.08x | 2.75x | 5.79x | 16.09x | 19.89x | 19.37B | ||
| -.--% | -.--% | 22.45x | 2.64x | 4.26x | 13.93x | 15.83x | 17.15B | ||
| -.--% | -.--% | -329.86x | 11.84x | 27.4x | 1508.36x | -330.88x | 13.54B | ||
| -.--% | -.--% | -14.37x | 62.88x | 6424.77x | -18.36x | -13.86x | 12.66B | ||
| -.--% | -.--% | -172.74x | 19.08x | 42.14x | -167.37x | -152.68x | 12.33B | ||
| -.--% | -.--% | 13.5x | 3.48x | 3.75x | 8.9x | 10.01x | 10.72B | ||
| -.--% | -.--% | -85.77x | 16.43x | 6.32x | -94.47x | -65.2x | 9.93B | ||
| -.--% | -.--% | -7.89x | - | - | -6.99x | -6.78x | 8.38B | ||
| -.--% | -.--% | -17.13x | 15.42x | 16.51x | -23.48x | -16.54x | 8.29B | ||
| -.--% | -.--% | -17.99x | 6.12x | 509.09x | -15.71x | -15.87x | 8.04B | ||
| 0.25% | 0.29% | 33.47x | 6.36x | 9.68x | 24.41x | 25.12x | 7.83B | ||
| -.--% | -.--% | -216.42x | 17.05x | 20.06x | 357.18x | -454.91x | 8.42B | ||
| Average | 0.13% | 0.13% | -47.99x | 17.94x | 473.76x | 89.97x | -61.58x | 16.29B | |
| Weighted average by Cap. | 0.29% | 0.26% | -28.62x | 19.67x | 331.14x | 74.38x | -36.55x |
- Stock Market
- Equities
- PVLA Stock
- Sector Palvella Therapeutics, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















